Journal of Ethnopharmacology · 2023 · 13 citations · 43 references
MedicineDermatologyPharmacologyEthnobotanyImmunopathologyInflammationAnti-inflammatory PharmacologyImmunopathology Of SkinInflammation PharmacologyInflammatory Skin DiseasesMedicinal Plant KnowledgeMedicinal PlantsAnti-inflammatory ActivityAqueous Plant ExtractsAssayExtractGuinea Pig ModelsPharmacological ProfilingPharmacological ScreeningPharmacological Therapy
ETHNOPHARMACOLOGICAL RELEVANCE: Artemisia annua L. belongs to the Asteraceae family and has a long history of clinical application in China. It has been widely used for centuries to treat fever, malaria, jaundice and some skin diseases (such as scabies and sores). Modern pharmacological studies have shown that it has anti-inflammatory, immunomodulatory, antimalarial and antibacterial effects. AIM OF STUDY: This study aimed to investigate the anti-eczema effect of A. annua aqueous extract (AAE), profile its potential bioactive components and try to explore its possible underlying mechanisms. MATERIALS AND METHODS: The MTT assay was employed to assess the cytotoxicity of AAE. The anti-eczema effect of AAE was evaluated using both an in vitro 3D epidermal inflammation model and an in vivo guinea pig itching model. The bioactive components of AAE were characterized by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry coupled with the UNIFI platform. RESULTS: In this study, we found that AAE is safe for primary human skin keratinocytes at concentrations ranging from 31.3 μg/mL to 250 μg/mL. Further investigations indicate that AAE can increase the itching threshold, inhibit the expression of the inflammatory cytokine TSLP, and promote the expression of FLG mRNA. Additionally, the utilization of UPLC-QTOF/MS and UNIFI platform enabled us to identify 61 potential bioactive components of AAE, with sesquiterpenes and phenolic acids being the most abundant components. CONCLUSIONS: In this study, the anti-inflammatory and anti-itch effects of the A. annua extract were revealed, along with sesquiterpenes and phenolic acids were identified as potential bioactive components according to literature. The AAE extract holds potential for utilization in the treatment of eczema.
43
Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial
Joanne R Chalmers, Rachel Haines, Lucy Bradshaw et al. · The Lancet · 2020 · 309 citations · Full text
Medicine, Dermatology, Pediatrics +17
Jian Han, Min Ye, Xue Qiao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2008 · 164 citations